You are here: Industry Insights > COVID-19 vaccine

News List

EU warns about tougher export control of COVID vaccines as internal feuds intensify expresspharma
March 19, 2021
The European Commission threatened to ban COVID-19 vaccine exports to countries like Britain that have higher vaccination rates but do not export shots to the EU, as rifts over the scarcity of the shots deepened and the 27-nation bloc struggled to ...
SII gets purchase order from government for 10 crore doses of Covishield expresspharma
March 19, 2021
Serum Institute of India (SII) has received a new purchase order from the Government of India for the supply of 10-crore doses of the Oxford-AstraZeneca COVID-19 vaccine — Covishield — each dose costing Rs 157.5, including GST, according to official ...
J&J developing many next-gen vaccines against COVID-19: CEO expresspharma
March 19, 2021
Johnson & Johnson is developing several next-generation COVID-19 vaccines against the emerging variants of the coronavirus, said Alex Gorsky, CEO of the company.
GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine pharmatimes
March 18, 2021
GlaxoSmithKline (GSK) and Canadian biopharma company Medicago have launched a Phase III trial of their adjuvanted plant-derived COVID-19 vaccine candidate.
Frontline charities sign open letter backing COVID-19 vaccination drive pharmatimes
March 17, 2021
A partnership of frontline health charities has signed an open letter encouraging people with underlying conditions to book in for a COVID-19 vaccine.
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses expresspharma
March 17, 2021
Gland Pharma has signed a deal with the Russian Direct Investment Fund (RDIF) to make up to 252 million doses of the Sputnik V COVID-19 vaccine, bringing India’s total production of the shot to at least 352 million.
Moderna commences trial of COVID-19 vaccine in children expresspharma
March 17, 2021
The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart in children aged six months to less than 12 years.
First participants dosed in Phase 1 study evaluating mRNA-1283, Moderna's next generation COVID-19 vaccine worldpharmanews
March 16, 2021
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the first participants have been dosed in the Phase 1 study of mRNA-1283, the Company's next generation COVID-19 vaccine candidate.
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine contractpharma
March 16, 2021
Takeda Pharmaceutical has entered a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization (CDMO), to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture ...
EU countries suspend use of Covid-19 vaccine AstraZeneca pharmaceutical-technology
March 16, 2021
Several countries in Europe have suspended the University of Oxford / AstraZeneca (AZ) Covid-19 vaccine completely or partially after several suspected deaths were reported due to blood clotting following vaccination.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page